Form 4: Monte Rosa Therapeutics CEO Sells Shares
Insider Transaction (Form 4)
Markus Warmuth, President & CEO and a Director of Monte Rosa Therapeutics, Inc., sold 9,500 shares of common stock on July 16, 2026 for $23.18 per share.
Summary
- Open-market sale: disposed of 9,500 Common Stock at $23.18 ($220,219) on July 16, 2026; holds 585,038 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $220,219 of stock on the open market.
Insider Transactions
Markus Warmuth — Director, Officer (President & CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-16 | Open-market sale | Common Stock | 9,500 | $23 | $220.2K | 585,038 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-16 | Open-market sale (9,500 shares) |
Keywords
insider transaction, Form 4, GLUE, Monte Rosa Therapeutics, Inc., bearish, Markus Warmuth
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.